BCAS2 Antikörper (AA 151-225)
Kurzübersicht für BCAS2 Antikörper (AA 151-225) (ABIN718811)
Target
Alle BCAS2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-225
-
Verwendungszweck
- BCAS2 Polyclonal Antibody
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BCAS2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
-
Andere Bezeichnung
- BCAS2
-
Hintergrund
-
Synonyms: DAM1, SPF27, Snt309, Pre-mRNA-splicing factor SPF27, Breast carcinoma-amplified sequence 2, DNA amplified in mammary carcinoma 1 protein, Spliceosome-associated protein SPF 27, BCAS2
Background: Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex.
-
Gen-ID
- 10286
-
UniProt
- O75934
Target
-